GLYC — GlycoMimetics Cashflow Statement
0.000.00%
Last trade - 00:00- $124.07m
- $82.27m
- $0.01m
Annual cashflow statement for GlycoMimetics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -57.9 | -51 | -63.4 | -46.7 | -36.9 |
| Depreciation | |||||
| Non-Cash Items | 6.84 | 7.58 | 6.84 | 4.69 | 4.43 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.21 | 3.93 | -1.17 | -4.66 | -2.56 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -52 | -39.2 | -57.5 | -46.5 | -34.9 |
| Capital Expenditures | -0.145 | -0.069 | -0.015 | -0.084 | -0.021 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.145 | -0.069 | -0.015 | -0.084 | -0.021 |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 0.413 | 18.1 | 10.7 | 4.16 | 28.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -51.7 | -21.2 | -46.8 | -42.4 | -6.08 |